Decision | Consent granted Section 12(b) Overseas Investment Act 2005 Section 13(1)(a) Overseas Investment Act 2005 |
---|---|
Decision Date | 3 December 2015 |
Investment | An overseas investment in sensitive land, being the Applicant's acquisition of rights or interests in 39.5% of the units in each of EHPO Trust and EHPP Trust, which, at the time of the investment, will own or control:
|
Consideration | $69,146,772 |
Applicant | MTGRP, L.L.C United States Public (76.21%) Various overseas persons (17.97%) United Kingdom Public (5.82%) |
Vendor | EHPO Trust and EHPP Trust Australia (100%) |
Background | The Applicant's investment in the EHPO Trust and EHPP Trust, will fund the acquisition by Evolution Healthcare (NZ) Pty Limited of rights or interests in 100% of the shares in Austron Limited (refer decision 201520005) which owns or controls the following sensitive land:
The Applicant's investment in the Trusts will also enable Evolution Healthcare (NZ) Pty Limited to undertake the significant developments of Wakefield Hospital and Royston Hospital outlined in decision 201520005. The Applicant's investment in the EHPO Trust and EHPP Trust will enable the Trusts’ subsidiary, Evolution Healthcare (NZ) Pty Limited to acquire and then undertake the significant developments of Wakefield Hospital and Royston Hospital outlined in decision 201520005. The overseas investment transaction has satisfied the criteria in sections 16 and 18 of the Overseas Investment Act 2005. The 'benefit to New Zealand' criterion was satisfied by particular reference to the following factors: Overseas Investment Regulations 2005 |
More information | Susie Kilty Buddle Findlay PO Box 2694 WELLINGTON 6140 |